Your browser doesn't support javascript.
loading
AXL - a new player in resistance to HER2 blockade.
Adam-Artigues, Anna; Arenas, Enrique J; Arribas, Joaquín; Prat, Aleix; Cejalvo, Juan Miguel.
Afiliación
  • Adam-Artigues A; INCLIVA Biomedical Research Institute, Spain. Electronic address: anar4@alumni.uv.es.
  • Arenas EJ; Josep Carreras Leukaemia Research Institute, Spain; Center for Biomedical Network Research on Cancer (CIBERONC), Spain. Electronic address: earenas@vhio.net.
  • Arribas J; Center for Biomedical Network Research on Cancer (CIBERONC), Spain; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Spain; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Spain; Department of Biochemistry and Molecular Biology, Universitat Autón
  • Prat A; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain; SOLTI Breast Cancer Research Group, Spain. Electronic address: ALPRAT@clinic.cat.
  • Cejalvo JM; INCLIVA Biomedical Research Institute, Spain; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Spain; Department of Medical Oncology, Hospital Clínico Universitario de València, Spain. Electronic address: jmcejalvo@incliva.es.
Cancer Treat Rev ; 121: 102639, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37864955

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Tirosina Quinasa del Receptor Axl Límite: Female / Humans Idioma: En Revista: Cancer Treat Rev Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Tirosina Quinasa del Receptor Axl Límite: Female / Humans Idioma: En Revista: Cancer Treat Rev Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos